Talecris Biotherapeutics News
Most Popular Talecris Biotherapeutics Story
Talecris launches IPO
Talecris Biotherapeutics has launched its ice-breaking IPO, saying it will sell 44.7 million shares at $18 to $20 per share. Analysts say the life sciences offering is solid proof that the once Read more...
Latest Headlines
- June 7, 2010
- November 13, 2009
- October 1, 2009
- September 15, 2009
- July 28, 2009
- June 9, 2009
- June 8, 2009
- May 29, 2009
- May 26, 2009
- August 13, 2008
- July 30, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
